LegiPlex
Legislation Monitoring
& Workspaces
US
Federal
& States
About
Sign Up
Login
...
US
US Federal US
Legislatures
2025-2026 Regular Session
Senate
Bills
SB652
US
US Federal Senate Bill SB652
US Federal 2025-2026 Regular Session
Overview
Activity Timeline
Videos
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Menu
US
US Federal 2025-2026 Regular Session
US Federal Senate Bill SB652
Introduced
2/20/25
Refer
2/20/25
Caption
Protecting Patients from Deceptive Drug Ads Act
Congress_id
119-S-652
Policy_area
Health
Introduced_date
2025-02-20
Latest US SB652 Activity
View All Events: US 2025-2026 Regular Session SB652
Companion Bills
No companion bills found.
Previously Filed As
US SB2712
Protecting Patient Access to Physician-Administered Drugs Act; enact.
US HB17
Protecting Patient Access to Physician-Administered Drugs Act; create.
US H2472
Protecting patient safety regarding non-FDA approved drugs
US S1497
Protecting patient safety regarding non-FDA approved drugs
US HB06870
An Act Addressing Patients' Prescription Drug Costs.
US HB1090
Protections Against Deceptive Pricing Practices
US HB7980
Protecting Americans from Unsafe Drugs Act of 2026
US SB2699
Patient's Right to Informed Health Care Choices Act & prohibitions against deceptive advertising by providers; delete repealers on.
US HB6906
Protecting Patients from Rehab Fraud Act of 2025
US SB2667
Nurse practitioners; authorize to dispense legend drugs to patients.
Similar Bills
No similar bills found.